4//SEC Filing
FUCHS HENRY J 4
Accession 0001048477-24-000034
CIK 0001048477other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 6:54 PM ET
Size
4.9 KB
Accession
0001048477-24-000034
Insider Transaction Report
Form 4
FUCHS HENRY J
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-03-05$85.18/sh−35,341$3,010,396→ 212,117 total
Footnotes (1)
- [F1]The price in column 4 is the weighted average price. The purchase price actually received ranged from $85.01 to $85.31. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
Documents
Issuer
BIOMARIN PHARMACEUTICAL INC
CIK 0001048477
Entity typeother
Related Parties
1- filerCIK 0001197355
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 6:54 PM ET
- Size
- 4.9 KB